Iksuda Therapeutics logo
Healthcare & Life Sciences

Iksuda Therapeutics

United Kingdomiksuda.com/

Iksuda Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Iksuda Therapeutics

Iksuda Therapeutics is a startup based in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Iksuda Therapeutics is a biotechnology company developing antibody drug conjugates (ADCs) for difficult-to-treat cancers. It has a clinical-stage pipeline and a new protein alkylating payload class called ProAlk.

Explore Iksuda Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United Kingdom